Cervical cancer screening in women with systemic lupus erythematosus
Arthritis Care & Research — Bruera S, Lei X, Zogala R, et al. | October 22, 2021
Researchers examined the rates of cervical cancer screening, as well as associated abnormal results, among women with an initial diagnosis of systemic lupus erythematosus (SLE).
Included were 4,316 women with SLE and age-matched women without connective tissue disease.
Relative to the general controls, women with SLE had higher screening rates.
Decreased screening was observed in correlation with the following factors: recent time (2012–2014 vs 2001–2005), age ≥ 61 years, comorbidity score ≥ 2, corticosteroid use, and use of immunosuppressants.
Women with SLE more commonly had abnormal pathology result claims relative to general controls, supporting the need for regular screening.
Overall findings suggest that despite higher rates than the general cohort, screening is not performed in over 25% of the patients with SLE, and there has been a decrease in screening rates over time.
Read the full article on Arthritis Care & Research